+Follow
星之心
No personal profile
24
Follow
6
Followers
0
Topic
0
Badge
Posts
Hot
星之心
2020-07-08
xni
Onconova Therapeutics Inc. experienced intraday volatility, plunging 5.58% to $0.540 in early trading.
星之心
2019-11-06
$SELLAS Life Sciences Group Inc.(SLS)$
upupup
Go to Tiger App to see more news
{"i18n":{"language":"en_US"},"userPageInfo":{"id":"3516396034245075","uuid":"3516396034245075","gmtCreate":1553302199240,"gmtModify":1553302199240,"name":"星之心","pinyin":"xzxxingzhixin","introduction":"","introductionEn":null,"signature":"","avatar":"https://static.tigerbbs.com/5e56318f05277256f547366bf476bc94","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":6,"headSize":24,"tweetSize":66,"questionSize":0,"limitLevel":999,"accountStatus":3,"level":{"id":3,"name":"书生虎","nameTw":"書生虎","represent":"努力向上","factor":"发布10条非转发主帖,其中5条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":"init","userBadges":[{"badgeId":"1026c425416b44e0aac28c11a0848493-4","templateUuid":"1026c425416b44e0aac28c11a0848493","name":"Tiger Star","description":"Join the tiger community for 2000 days","bigImgUrl":"https://static.tigerbbs.com/dddf24b906c7011de2617d4fb3f76987","smallImgUrl":"https://static.tigerbbs.com/53d58ad32c97254c6f74db8b97e6ec49","grayImgUrl":"https://static.tigerbbs.com/6304700d92ad91c7a33e2e92ec32ecc1","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2026.04.22","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001,"isScarce":0,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0}],"userBadgeCount":1,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":1,"crmLevelSwitch":0,"location":null,"starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"hot","tweets":[{"id":949386199,"gmtCreate":1594148689311,"gmtModify":1705044011465,"author":{"id":"3516396034245075","authorId":"3516396034245075","name":"星之心","avatar":"https://static.tigerbbs.com/5e56318f05277256f547366bf476bc94","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3516396034245075","idStr":"3516396034245075"},"themes":[],"title":"","htmlText":"xni","listText":"xni","text":"xni","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/949386199","repostId":"2046623376","repostType":2,"repost":{"id":"2046623376","kind":"news","pubTimestamp":1593182465,"share":"https://ttm.financial/m/news/2046623376?lang=en_US&edition=fundamental","pubTime":"2020-06-26 22:41","market":"us","language":"zh","title":"Onconova Therapeutics Inc. experienced intraday volatility, plunging 5.58% to $0.540 in early trading.","url":"https://stock-news.laohu8.com/highlight/detail?id=2046623376","media":"自选股智能写手","summary":"北京时间2020年06月26日22时41分，Onconova Therapeutics Inc（ONTX.us）股票出现波动，股价急速跳水5.58%。截至发稿，该股报0.540美元/股，成交量228.","content":"<p><html><body><article>At 22:41 Beijing time on June 26, 2020, the stock of Onconova Therapeutics Inc (ONTX.us) fluctuated, and the stock price plummeted by 5.58%. As of press time, the stock was trading at $0.540 per share, with a trading volume of 2,285,820 shares, a turnover rate of 1.36%, and a volatility of 6.14%.</p><p>Recent financial reports show that the company achieved operating revenue of $52,000.00, net profit of -$5.09 million, earnings per share of -$0.03, gross profit of --, and P/E of -2.35 times.</p><p>Regarding institutional ratings, among all four institutions that participated in the rating, 100% of the securities firms gave a buy recommendation, while no securities firms gave a hold or sell recommendation.</p><p>In the biotechnology industry, where Onconova Therapeutics Inc. stock is listed, the overall decline was 1.99%. Among its related stocks, Vaxart Inc, Citius Pharmaceuticals Inc, and Ibio Inc saw significant gains. They were relatively active, with turnover rates of 155.76%, 102.43%, and 62.38% respectively. Related stocks with significant fluctuations included: Vaxart Inc, Citius Pharmaceuticals Inc,<a href=\"https://laohu8.com/S/CBLI\">Cleveland Biological Lab</a>The amplitudes were 76.36%, 57.41%, and 38.37%, respectively.</p><p>Onconova Therapeutics Inc Company Profile: Onconova Therapeutics Inc is a clinical-stage biopharmaceutical company operating in the United States. It focuses on the discovery and development of novel small molecule product candidates primarily for the treatment of cancer. The company has created a targeted reagent library designed to combat important cellular pathways of cancer cells. Its product candidates are IV rigosertib, oral rigosertib + azacitidine, IV Briciclib, Recilisib and ON123300. The main product candidate, Rigosertib, is a small molecule that can block signaling by targeting the RAS effective cellular pathway.</p><p>(The above content refers to stock picks.)<a href=\"https://laohu8.com/S/5RE.SI\">smart</a>The machine writer's Money Call is completed and is for user reference only, not as a basis for trading.</p><p></article></body></html></p>","source":"tencent","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Onconova Therapeutics Inc. experienced intraday volatility, plunging 5.58% to $0.540 in early trading.</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nOnconova Therapeutics Inc. experienced intraday volatility, plunging 5.58% to $0.540 in early trading.\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">自选股智能写手</strong><span class=\"h-time small\">2020-06-26 22:41</span>\n</p>\n</h4>\n</header>\n<article>\n<p><html><body><article>At 22:41 Beijing time on June 26, 2020, the stock of Onconova Therapeutics Inc (ONTX.us) fluctuated, and the stock price plummeted by 5.58%. As of press time, the stock was trading at $0.540 per share, with a trading volume of 2,285,820 shares, a turnover rate of 1.36%, and a volatility of 6.14%.</p><p>Recent financial reports show that the company achieved operating revenue of $52,000.00, net profit of -$5.09 million, earnings per share of -$0.03, gross profit of --, and P/E of -2.35 times.</p><p>Regarding institutional ratings, among all four institutions that participated in the rating, 100% of the securities firms gave a buy recommendation, while no securities firms gave a hold or sell recommendation.</p><p>In the biotechnology industry, where Onconova Therapeutics Inc. stock is listed, the overall decline was 1.99%. Among its related stocks, Vaxart Inc, Citius Pharmaceuticals Inc, and Ibio Inc saw significant gains. They were relatively active, with turnover rates of 155.76%, 102.43%, and 62.38% respectively. Related stocks with significant fluctuations included: Vaxart Inc, Citius Pharmaceuticals Inc,<a href=\"https://laohu8.com/S/CBLI\">Cleveland Biological Lab</a>The amplitudes were 76.36%, 57.41%, and 38.37%, respectively.</p><p>Onconova Therapeutics Inc Company Profile: Onconova Therapeutics Inc is a clinical-stage biopharmaceutical company operating in the United States. It focuses on the discovery and development of novel small molecule product candidates primarily for the treatment of cancer. The company has created a targeted reagent library designed to combat important cellular pathways of cancer cells. Its product candidates are IV rigosertib, oral rigosertib + azacitidine, IV Briciclib, Recilisib and ON123300. The main product candidate, Rigosertib, is a small molecule that can block signaling by targeting the RAS effective cellular pathway.</p><p>(The above content refers to stock picks.)<a href=\"https://laohu8.com/S/5RE.SI\">smart</a>The machine writer's Money Call is completed and is for user reference only, not as a basis for trading.</p><p></article></body></html></p>\n<div class=\"bt-text\">\n\n\n<p> source：<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2020062622410779ef09c9&s=b\">自选股智能写手</a></p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/6ad7ed6b96b448ffcc5b5501b0dc346c","relate_stocks":{"ONTX":"CORGI ONTO 2X DAILY ETF"},"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2020062622410779ef09c9&s=b","is_english":false,"share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","article_id":"2046623376","content_text":"北京时间2020年06月26日22时41分，Onconova Therapeutics Inc（ONTX.us）股票出现波动，股价急速跳水5.58%。截至发稿，该股报0.540美元/股，成交量228.582万股，换手率1.36%，振幅6.14%。最近的财报数据显示，该股实现营业收入52000.00美元，净利润-5.09百万美元，每股收益-0.03美元，毛利--，市盈率-2.35倍。机构评级方面，在所有4家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。Onconova Therapeutics Inc股票所在的生物技术行业中，整体跌幅为1.99%。其相关个股中，Vaxart Inc、Citius Pharmaceuticals Inc、Ibio Inc涨幅较大，Vaxart Inc、Citius Pharmaceuticals Inc、Ibio Inc较为活跃，换手率分别为155.76%、102.43%、62.38%，振幅较大的相关个股有Vaxart Inc、Citius Pharmaceuticals Inc、克利夫兰生物实验室，振幅分别为76.36%、57.41%、38.37%。Onconova Therapeutics Inc公司简介：Onconova Therapeutics Inc是一家在美国运营的临床阶段生物制药公司。 它专注于发现和开发主要用于治疗癌症的新型小分子产品候选物。 该公司创建了一个针对性试剂库，旨在对抗癌细胞重要的细胞途径。 它的候选产品为IV rigosertib，口服rigosertib +阿扎胞苷，IV Briciclib，Recilisib和ON123300。主要候选产品Rigosertib是一种小分子，可通过靶向RAS有效细胞途径来阻断信号传导。（以上内容为自选股智能机器写手Money Call完成，仅作为用户看盘参考，不作为交易依据。）","news_type":1,"symbols_score_info":{"ONTX":0.9}},"isVote":1,"tweetType":1,"viewCount":3972,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":932519805,"gmtCreate":1572976588707,"gmtModify":1705411172556,"author":{"id":"3516396034245075","authorId":"3516396034245075","name":"星之心","avatar":"https://static.tigerbbs.com/5e56318f05277256f547366bf476bc94","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3516396034245075","idStr":"3516396034245075"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/SLS\">$SELLAS Life Sciences Group Inc.(SLS)$</a>upupup","listText":"<a href=\"https://laohu8.com/S/SLS\">$SELLAS Life Sciences Group Inc.(SLS)$</a>upupup","text":"$SELLAS Life Sciences Group Inc.(SLS)$upupup","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/932519805","isVote":1,"tweetType":1,"viewCount":4080,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"hots":[{"id":949386199,"gmtCreate":1594148689311,"gmtModify":1705044011465,"author":{"id":"3516396034245075","authorId":"3516396034245075","name":"星之心","avatar":"https://static.tigerbbs.com/5e56318f05277256f547366bf476bc94","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3516396034245075","authorIdStr":"3516396034245075"},"themes":[],"title":"","htmlText":"xni","listText":"xni","text":"xni","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/949386199","repostId":"2046623376","repostType":2,"repost":{"id":"2046623376","kind":"news","pubTimestamp":1593182465,"share":"https://ttm.financial/m/news/2046623376?lang=en_US&edition=fundamental","pubTime":"2020-06-26 22:41","market":"us","language":"zh","title":"Onconova Therapeutics Inc. experienced intraday volatility, plunging 5.58% to $0.540 in early trading.","url":"https://stock-news.laohu8.com/highlight/detail?id=2046623376","media":"自选股智能写手","summary":"北京时间2020年06月26日22时41分，Onconova Therapeutics Inc（ONTX.us）股票出现波动，股价急速跳水5.58%。截至发稿，该股报0.540美元/股，成交量228.","content":"<p><html><body><article>At 22:41 Beijing time on June 26, 2020, the stock of Onconova Therapeutics Inc (ONTX.us) fluctuated, and the stock price plummeted by 5.58%. As of press time, the stock was trading at $0.540 per share, with a trading volume of 2,285,820 shares, a turnover rate of 1.36%, and a volatility of 6.14%.</p><p>Recent financial reports show that the company achieved operating revenue of $52,000.00, net profit of -$5.09 million, earnings per share of -$0.03, gross profit of --, and P/E of -2.35 times.</p><p>Regarding institutional ratings, among all four institutions that participated in the rating, 100% of the securities firms gave a buy recommendation, while no securities firms gave a hold or sell recommendation.</p><p>In the biotechnology industry, where Onconova Therapeutics Inc. stock is listed, the overall decline was 1.99%. Among its related stocks, Vaxart Inc, Citius Pharmaceuticals Inc, and Ibio Inc saw significant gains. They were relatively active, with turnover rates of 155.76%, 102.43%, and 62.38% respectively. Related stocks with significant fluctuations included: Vaxart Inc, Citius Pharmaceuticals Inc,<a href=\"https://laohu8.com/S/CBLI\">Cleveland Biological Lab</a>The amplitudes were 76.36%, 57.41%, and 38.37%, respectively.</p><p>Onconova Therapeutics Inc Company Profile: Onconova Therapeutics Inc is a clinical-stage biopharmaceutical company operating in the United States. It focuses on the discovery and development of novel small molecule product candidates primarily for the treatment of cancer. The company has created a targeted reagent library designed to combat important cellular pathways of cancer cells. Its product candidates are IV rigosertib, oral rigosertib + azacitidine, IV Briciclib, Recilisib and ON123300. The main product candidate, Rigosertib, is a small molecule that can block signaling by targeting the RAS effective cellular pathway.</p><p>(The above content refers to stock picks.)<a href=\"https://laohu8.com/S/5RE.SI\">smart</a>The machine writer's Money Call is completed and is for user reference only, not as a basis for trading.</p><p></article></body></html></p>","source":"tencent","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Onconova Therapeutics Inc. experienced intraday volatility, plunging 5.58% to $0.540 in early trading.</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nOnconova Therapeutics Inc. experienced intraday volatility, plunging 5.58% to $0.540 in early trading.\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">自选股智能写手</strong><span class=\"h-time small\">2020-06-26 22:41</span>\n</p>\n</h4>\n</header>\n<article>\n<p><html><body><article>At 22:41 Beijing time on June 26, 2020, the stock of Onconova Therapeutics Inc (ONTX.us) fluctuated, and the stock price plummeted by 5.58%. As of press time, the stock was trading at $0.540 per share, with a trading volume of 2,285,820 shares, a turnover rate of 1.36%, and a volatility of 6.14%.</p><p>Recent financial reports show that the company achieved operating revenue of $52,000.00, net profit of -$5.09 million, earnings per share of -$0.03, gross profit of --, and P/E of -2.35 times.</p><p>Regarding institutional ratings, among all four institutions that participated in the rating, 100% of the securities firms gave a buy recommendation, while no securities firms gave a hold or sell recommendation.</p><p>In the biotechnology industry, where Onconova Therapeutics Inc. stock is listed, the overall decline was 1.99%. Among its related stocks, Vaxart Inc, Citius Pharmaceuticals Inc, and Ibio Inc saw significant gains. They were relatively active, with turnover rates of 155.76%, 102.43%, and 62.38% respectively. Related stocks with significant fluctuations included: Vaxart Inc, Citius Pharmaceuticals Inc,<a href=\"https://laohu8.com/S/CBLI\">Cleveland Biological Lab</a>The amplitudes were 76.36%, 57.41%, and 38.37%, respectively.</p><p>Onconova Therapeutics Inc Company Profile: Onconova Therapeutics Inc is a clinical-stage biopharmaceutical company operating in the United States. It focuses on the discovery and development of novel small molecule product candidates primarily for the treatment of cancer. The company has created a targeted reagent library designed to combat important cellular pathways of cancer cells. Its product candidates are IV rigosertib, oral rigosertib + azacitidine, IV Briciclib, Recilisib and ON123300. The main product candidate, Rigosertib, is a small molecule that can block signaling by targeting the RAS effective cellular pathway.</p><p>(The above content refers to stock picks.)<a href=\"https://laohu8.com/S/5RE.SI\">smart</a>The machine writer's Money Call is completed and is for user reference only, not as a basis for trading.</p><p></article></body></html></p>\n<div class=\"bt-text\">\n\n\n<p> source：<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2020062622410779ef09c9&s=b\">自选股智能写手</a></p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/6ad7ed6b96b448ffcc5b5501b0dc346c","relate_stocks":{"ONTX":"CORGI ONTO 2X DAILY ETF"},"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2020062622410779ef09c9&s=b","is_english":false,"share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","article_id":"2046623376","content_text":"北京时间2020年06月26日22时41分，Onconova Therapeutics Inc（ONTX.us）股票出现波动，股价急速跳水5.58%。截至发稿，该股报0.540美元/股，成交量228.582万股，换手率1.36%，振幅6.14%。最近的财报数据显示，该股实现营业收入52000.00美元，净利润-5.09百万美元，每股收益-0.03美元，毛利--，市盈率-2.35倍。机构评级方面，在所有4家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。Onconova Therapeutics Inc股票所在的生物技术行业中，整体跌幅为1.99%。其相关个股中，Vaxart Inc、Citius Pharmaceuticals Inc、Ibio Inc涨幅较大，Vaxart Inc、Citius Pharmaceuticals Inc、Ibio Inc较为活跃，换手率分别为155.76%、102.43%、62.38%，振幅较大的相关个股有Vaxart Inc、Citius Pharmaceuticals Inc、克利夫兰生物实验室，振幅分别为76.36%、57.41%、38.37%。Onconova Therapeutics Inc公司简介：Onconova Therapeutics Inc是一家在美国运营的临床阶段生物制药公司。 它专注于发现和开发主要用于治疗癌症的新型小分子产品候选物。 该公司创建了一个针对性试剂库，旨在对抗癌细胞重要的细胞途径。 它的候选产品为IV rigosertib，口服rigosertib +阿扎胞苷，IV Briciclib，Recilisib和ON123300。主要候选产品Rigosertib是一种小分子，可通过靶向RAS有效细胞途径来阻断信号传导。（以上内容为自选股智能机器写手Money Call完成，仅作为用户看盘参考，不作为交易依据。）","news_type":1,"symbols_score_info":{"ONTX":0.9}},"isVote":1,"tweetType":1,"viewCount":3972,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":932519805,"gmtCreate":1572976588707,"gmtModify":1705411172556,"author":{"id":"3516396034245075","authorId":"3516396034245075","name":"星之心","avatar":"https://static.tigerbbs.com/5e56318f05277256f547366bf476bc94","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3516396034245075","authorIdStr":"3516396034245075"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/SLS\">$SELLAS Life Sciences Group Inc.(SLS)$</a>upupup","listText":"<a href=\"https://laohu8.com/S/SLS\">$SELLAS Life Sciences Group Inc.(SLS)$</a>upupup","text":"$SELLAS Life Sciences Group Inc.(SLS)$upupup","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/932519805","isVote":1,"tweetType":1,"viewCount":4080,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"lives":[]}
